These drugs did not change pituitary weight and plasma PRL levels in AD and PF rats, suggesting that the epigenetic modulatory drugs reverse fetal alcohol induced epigenetic modifications thereby increasing D2R expression that results in reduced pituitary weight and plasma PRL levels. This evidence concerns the gene DRD2 and Alzheimer disease.